News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Knowles Julius
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 01/20/2023 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Bought 1,191 shares
@ $20.98, valued at
$25k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 3,678 shares
@ $56.82, valued at
$209k
Sold 2,406 shares
@ $56.82, valued at
$136.7k
Sold 5,094 shares
@ $57.83, valued at
$294.6k
Sold 3,318 shares
@ $57.83, valued at
$191.9k
Sold 5,236 shares
@ $58.96, valued at
$308.7k
Sold 3,412 shares
@ $58.96, valued at
$201.2k
Sold 249 shares
@ $59.4, valued at
$14.8k
Sold 162 shares
@ $59.4, valued at
$9.6k
Sold 794 shares
@ $54.95, valued at
$43.6k
Sold 524 shares
@ $54.95, valued at
$28.8k
Sold 2,124 shares
@ $56.1, valued at
$119.2k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 7,057 shares
@ $41.85, valued at
$295.3k
Sold 4,599 shares
@ $41.85, valued at
$192.5k
Sold 7,350 shares
@ $42.43, valued at
$311.9k
Sold 4,797 shares
@ $42.43, valued at
$203.5k
Sold 3,252 shares
@ $42.1, valued at
$136.9k
Sold 2,120 shares
@ $42.1, valued at
$89.3k
Sold 1,518 shares
@ $43.04, valued at
$65.3k
Sold 991 shares
@ $43.04, valued at
$42.7k
Sold 6,067 shares
@ $41.65, valued at
$252.7k
Sold 3,957 shares
@ $41.65, valued at
$164.8k
Sold 3,597 shares
@ $42.45, valued at
$152.7k
|
|
| 10/21/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2,029 shares
@ $38.05, valued at
$77.2k
Sold 1,323 shares
@ $38.05, valued at
$50.3k
Sold 704 shares
@ $38.49, valued at
$27.1k
Sold 460 shares
@ $38.49, valued at
$17.7k
Sold 229 shares
@ $37.55, valued at
$8.6k
Sold 148 shares
@ $37.55, valued at
$5.6k
Sold 2,242 shares
@ $38.31, valued at
$85.9k
Sold 1,463 shares
@ $38.31, valued at
$56k
|
|
| 10/18/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2,653 shares
@ $40.13, valued at
$106.5k
Sold 1,730 shares
@ $40.13, valued at
$69.4k
Sold 3,031 shares
@ $38.95, valued at
$118.1k
Sold 1,977 shares
@ $38.95, valued at
$77k
Sold 1,839 shares
@ $39.44, valued at
$72.5k
Sold 1,199 shares
@ $39.44, valued at
$47.3k
Sold 92 shares
@ $40.6, valued at
$3.7k
Sold 60 shares
@ $40.6, valued at
$2.4k
Sold 8,252 shares
@ $37.69, valued at
$311k
Sold 5,382 shares
@ $37.69, valued at
$202.8k
Sold 92 shares
@ $38.46, valued at
$3.5k
|
|
| 10/05/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 3,827 shares
@ $40.16, valued at
$153.7k
Sold 2,496 shares
@ $40.16, valued at
$100.2k
Sold 2,267 shares
@ $40.06, valued at
$90.8k
Sold 1,479 shares
@ $40.06, valued at
$59.2k
Sold 1,584 shares
@ $40.03, valued at
$63.4k
Sold 1,033 shares
@ $40.03, valued at
$41.4k
|
|
| 09/29/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 27,373 shares
@ $40.51, valued at
$1.1M
Sold 17,854 shares
@ $40.51, valued at
$723.3k
Sold 20,292 shares
@ $41.52, valued at
$842.5k
Sold 13,233 shares
@ $41.52, valued at
$549.4k
Sold 10,018 shares
@ $42.29, valued at
$423.7k
Sold 6,532 shares
@ $42.29, valued at
$276.2k
|
|
| 07/06/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 13,268 shares
@ $41.22, valued at
$546.9k
Sold 8,650 shares
@ $41.22, valued at
$356.6k
Sold 1,112 shares
@ $41.89, valued at
$46.6k
Sold 728 shares
@ $41.89, valued at
$30.5k
Sold 46 shares
@ $42.75, valued at
$2k
Sold 30 shares
@ $42.75, valued at
$1.3k
Sold 8,627 shares
@ $41.08, valued at
$354.4k
Sold 5,626 shares
@ $41.08, valued at
$231.1k
Sold 5,789 shares
@ $41.72, valued at
$241.5k
Sold 3,776 shares
@ $41.72, valued at
$157.5k
|
|
| 06/08/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2,988 shares
@ $47.23, valued at
$141.1k
Sold 1,950 shares
@ $47.23, valued at
$92.1k
Sold 1,018 shares
@ $48.15, valued at
$49k
Sold 663 shares
@ $48.15, valued at
$31.9k
Sold 703 shares
@ $46.48, valued at
$32.7k
Sold 459 shares
@ $46.48, valued at
$21.3k
Sold 786 shares
@ $47.34, valued at
$37.2k
Sold 512 shares
@ $47.34, valued at
$24.2k
Sold 560 shares
@ $48.76, valued at
$27.3k
Sold 366 shares
@ $48.76, valued at
$17.8k
Sold 870 shares
@ $50.02, valued at
$43.5k
|
|
| 06/03/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2,309 shares
@ $51.9, valued at
$119.8k
Sold 1,504 shares
@ $51.9, valued at
$78.1k
Sold 2,345 shares
@ $52.72, valued at
$123.6k
Sold 1,531 shares
@ $52.72, valued at
$80.7k
Sold 633 shares
@ $53.77, valued at
$34k
Sold 414 shares
@ $53.77, valued at
$22.3k
Sold 46 shares
@ $54.62, valued at
$2.5k
Sold 30 shares
@ $54.62, valued at
$1.6k
Sold 4,944 shares
@ $48.35, valued at
$239k
Sold 3,225 shares
@ $48.35, valued at
$155.9k
Sold 1,343 shares
@ $49.26, valued at
$66.2k
|
|
| 06/03/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 8,293 options to buy
@ $51.48, valued at
$426.9k
|
|
| 04/08/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,889 shares
@ $58.22, valued at
$110k
Sold 1,233 shares
@ $58.22, valued at
$71.8k
Sold 3,685 shares
@ $59.1, valued at
$217.8k
Sold 2,402 shares
@ $59.1, valued at
$142k
Sold 54 shares
@ $59.95, valued at
$3.2k
Sold 35 shares
@ $59.95, valued at
$2.1k
|
|
| 04/05/2021 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 3,790 shares
@ $58.42, valued at
$221.4k
Sold 2,472 shares
@ $58.42, valued at
$144.4k
Sold 2,350 shares
@ $59.08, valued at
$138.8k
Sold 1,533 shares
@ $59.08, valued at
$90.6k
Sold 434 shares
@ $60.82, valued at
$26.4k
Sold 283 shares
@ $60.82, valued at
$17.2k
Sold 206 shares
@ $61.36, valued at
$12.6k
Sold 134 shares
@ $61.36, valued at
$8.2k
Sold 298 shares
@ $58.66, valued at
$17.5k
Sold 195 shares
@ $58.66, valued at
$11.4k
Sold 5,445 shares
@ $59.76, valued at
$325.4k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2020 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Converted 276,459 shares
@ $0
Converted 184,305 shares
@ $0
Converted 205,962 shares
@ $0
Converted 137,308 shares
@ $0
Converted 67,015 shares
@ $0
Converted 44,676 shares
@ $0
Converted 276,459 preferred shares
@ $0
Converted 184,305 preferred shares
@ $0
Converted 205,962 preferred shares
@ $0
Converted 137,308 preferred shares
@ $0
Converted 67,015 preferred shares
@ $0 |
|
| 04/07/2020 |
3
| Knowles Julius (Director) has filed a Form 3 on Keros Therapeutics, Inc. |
|
|